General Information of the Compound
Compound ID |
CP0380262
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
5-chloro-3-(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylmethyl)-1,2,3,4-tetrahydroisoquinolin-8-ol
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C23H27ClN2O
|
||||||||||||||||||
Molecular Weight |
382.935
|
||||||||||||||||||
Canonical SMILES |
Oc1ccc(Cl)c2CC(CN3CCC4(CCc5ccccc45)CC3)NCc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C23H27ClN2O/c24-21-5-6-22(27)19-14-25-17(13-18(19)21)15-26-11-9-23(10-12-26)8-7-16-3-1-2-4-20(16)23/h1-6,17,25,27H,7-15H2
Show/Hide
|
||||||||||||||||||
InChIKey |
HBTHUUQDNVQVHD-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01360, Nociceptin receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2